Gamma glutamyl transpeptidase as a prognostic biomarker in hepatocellular cancer patients especially with >5 cm tumors, treated by liver transplantation.
Volkan InceBrian I CarrHarika Gözde Gözükara BağCemalettin KocSertac UstaVeysel ErsanAdil BaskiranTevfik Tolga SahinSezai YilmazPublished in: The International journal of biological markers (2020)
Elevated serum GGT levels were associated with HCC size and worse survival, and were unrelated to AFP levels. GGT may be a useful prognostic tumor marker, especially for low-AFP HCC patients.